1Sun Guanlin,Zhou Rongfu,Wu Wen,et al(The National Cooperarive Group of Leukemia Treatment with ATRA, 200025).481例急性早幼粒细胞白血病完全缓解后随访报告[J].中华血液学杂志,1994,15(8):411-413. 被引量：24
3Kwong Y L,Au W Y, Chim C S, et al. Arsenic trioxide-and idarubicin-induced remission in relapsed acute promyelocytic leukemia:clinicopathological and molecular features of a pilot study. Am J Hematol,2001,66:274-279.
4Koller E, Karilie H, Krieger U, et al. Early detection of minimal residual disease by reverse transcriptase polymerase chain reaction predicts relapse in APL. Am Hematola,1995,70:75-78.
5Huang W, Sun G L, Liu X S,et al, Acute promyelicytic leukemia: Clinical relevance of two major PML/RAR aisso-forms and detection of minimal disease by RT/PCR to predict relapse. Blood, 1993,82:1264-1269.
6Huan S Y,Yang C H,Chen Y C ,et al.Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: an useful salvage therapy. Leuk Lymphoma,2000,38:283-293.
7Korninger L,Knobl P,Laczika K,et al. PML-RARα PCR positivity in the patients with APL precedes hematological relapse by 2-3 months. Br J Hematol,1994,88:427-431.
8GRIMWADE D, BIONDI A , MOZZICONACCI M J , et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15:17):results of the European Working Party[J]. Blood, 2000,96:1297-1308.
9GRIMWADE D, GORMAN P, DUPREZ E, et al. Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia[J]. Blood, 1997, 90:4876-4885.
10PANTIC M, NOVAK A, MARISAVLJEVIC D, et al. Additional chromosome aberrations in acute promyelocytic leukemia: characteristics and prognostic influence[J]. Med Oncol, 2000 , 17:307-313.
